| Overall |
No PMRT |
Received PMRT |
||
| Characteristic |
N or Mean (%) |
N or Mean (%) |
N or Mean (%) |
p-value |
| Total patients |
72 |
55 |
17 |
-- |
| Age at mastectomy |
60 |
54 |
48 |
0.03 |
| Type of cancer |
||||
| DCIS |
8 (11.1) |
8 (14.5) |
0 (0) |
0.25 |
| Ductal |
56 (77.8) |
41 (74.6) |
15 (88.2) |
|
| Lobular |
8 (11.1) |
6 (10.9) |
2 (11.8) |
|
| Invasive tumor size |
||||
| 0 - 1 cm |
14 (19.4) |
12 (21.8) |
2 (11.8) |
0.23 |
| 1 - 2 cm |
28 (38.9) |
20 (36.4) |
8 (47.1) |
|
| 2 - 5 cm |
22 (30.1) |
15 (27.3) |
7 (41.2) |
|
| Histologic Grade |
||||
| 0 |
9 (12.5) |
9 (16.4) |
0 (0) |
0.321 |
| 1 |
12 (16.7) |
8 (14.6) |
4 (23.5) |
|
| 2 |
31 (43.1) |
23 (41.8) |
8 (47.1) |
|
| 3 |
20 (27.8) |
15 (27.3) |
5 (29.4) |
|
| Lymphovascular invasion (LVI) |
0.031 |
|||
| Absent |
60 (83.3) |
49 (89.1) |
11 (64.7) |
|
| Present |
12 (16.7) |
6 (10.9) |
6 (35.3) |
|
| Estrogen receptor status |
0.08 |
|||
| Negative |
21 (29.2) |
12 (23.6) |
8 (47.1) |
|
| Positive |
51 (70.8) |
42(76.4) |
9 (52.9) |
|
| Underwent chemotherapy |
0.041 |
|||
| No |
57 (79.2) |
47 (85.5) |
10 (58.9) |
|
| Yes |
15 (20.8) |
8 (14.55) |
7 (41.2) |
|
| Received endocrine therapy |
0.02 |
|||
| No |
51 (70.8) |
35 (63.6) |
16 (94.1) |
|
| Yes |
21 (29.2) |
20 (36.4) |
1 (5.9) |
|
| Recurrence |
7 (9.7) |
7 (12.7) |
0 (0) |
0.19 |
| Local |
4(5.6) |
4(7.3) |
0 (0) |
0.57 |
| Distal |
3 (4.2) |
3 (5.5) |
0 (0) |
0.99 |